Uses of inexpensive, personal, commercially-available, and portable EEG devices for medical research. Testing of new drugs, patient-specific drug selection, monitoring of patient progress, augmentation of treatments (via neurofeedback), prediction of 'attacks' in mental illnesses (e.g. panic disorder), and better diagnoses of neurological disorders.

1. Personal Neuro Devices:
Medical applications of
11/2/2012 mobile EEG 1

2. Electroencephalography (EEG)
 Reads brain activity
 Neurofeedback
therapy
 Can track aspects of
thought, emotion
11/2/2012
2

3. Mobile EEG
 Not bound to lab
 Links to smartphone
 Makes EEG monitoring
available anywhere
 Currently mostly for games
11/2/2012
3

4. PND: mobile EEG software
 Mobile EEG beyond games
 Treatment, diagnostics, self-
monitoring
 Team
 neuroscientists
 software engineers
 biomedical engineers
 business development
experts
11/2/2012
4

5. PND technologies: BackupBrain
 Stores EEG info online
 Accessible anywhere
 Deeper analysis
11/2/2012
5

6. PND technologies: Amygdala
 Backend for non-game
mobile EEG software
 Streamlines mobile EEG
development
 Algorithms, built-in GUIs,
links to BackupBrain, etc.
11/2/2012
6

7. Proof-of-concept: Transcend
 Neurofeedback-based mobile meditation app
 Comprehensive meditation tracking & analysis
 Reads relaxation, concentration, meditation
 uses in-house algorithms

8. Introspect
 EEG self-monitoring
 Records mental
states via EEG
waveform analysis

9. Introspect
 Detects: (e.g.)
 Mood
 Anxiety
 Stress
 Acute cognitive
functioning
 Sleep quality Example waveforms
linked to mental states
 Concentration
 Pain „unpleasantness‟

10. Introspect
 Detects problem areas
 Built-in neurofeedback exercises to
improve specific areas
PND neurofeedback game:
11/2/2012 psych showdown 10

11. Neurofeedback
 Training to directly
alter EEG output
 Mindfulness-based
 Meditation
 Effective treatment
 ADHD
 depression
 Anxiety
 etc.
11/2/2012
11

12. PND: Pharmaceutical uses
 Based on adaptations of Introspect
 Introspect malleable for
 Research
 Diagnostics
 Treatment
 Etc.

13. PND: Pharmaceutical uses
1) New drug testing
 mobile real-time drug efficacy monitoring
 E.g. observe mood in brain over time

14. PND: Pharmaceutical uses
2) Aid patient-specific
drug selection
 EEG patterns linked to
disorder etiologies
 Help hospital funding
11/2/2012
14

15. PND: Pharmaceutical uses
3) Monitor patient progress
 Ensure continued symptom
control
 Change treatments as
needed
Example mood and anxiety chart
11/2/2012
15

16. PND: Pharmaceutical uses
4) Augment treatments
 Raise overall efficacy
 Neurofeedback
11/2/2012
16

17. PND: Pharmaceutical uses
5) New class of as-
needed meds
 Alarm for impending
“attack”
 Preventative drug
used upon alarm
11/2/2012
17

18. PND: Pharmaceutical uses
6) Preventative medicine
 Catch “slipping” mental
health before disorder
develops

19. PND: Pharmaceutical uses
7) Diagnostics
 Link day-to-day mental
states to disorders
 Reduce reliance on
self-report
11/2/2012
19

20. Thank you!
Any questions?
20

21. References
• MacDonald, P. E., Rorsman, P. (2006). Oscillations, intercellular coupling, and insulin secretion in pancreatic beta
cells. PLoS Biol, 4(2): p49.
• Tatum, W. O., Husain, A. M., Benbadis, S. R. (2008). Handbook of EEG Interpretation. Demos Medical Publishing.
• Niedermeyer E. and da Silva F.L. (2004). Electroencephalography: Basic Principles, Clinical Applications, and Related
Fields. Lippincot Williams & Wilkins.
• Rubboli, G., Parra, J., Seri, S., Takahashi, T., & Thomas, P. (2004). EEG diagnostic procedures and special investigations in
the assessment of photosensitivity. Epilepsia, 45(s1), p35-39.
• Appleton, R., Macleod ,S., Martland ,T. (2008). Drug management for acute tonic-clonic convulsions including
convulsive status epilepticus in children. Cochrane Database of Systematic Reviews, 4: CD001905
• Randell T. (2004). "Medical and legal considerations of brain death". Acta Anaesthesiologica Scandinavica 48 (2): 139–
144
• Wijdicks EF. Determining brain death in adults. Neurology. 1995 May; 45(5): pp.1003-11
• Kupfer, D. J., Foster, F. G., Coble, P., McPartland, R. J., and Ulrich, R. F. (1978). The application of EEG sleep for the
differential diagnosis of affective disorders Am J Psychiatry 1978; 135:69-74
• Otto, K. A. (2008). EEG power spectrum analysis for monitoring depth of anaesthesia during experimental surgery; Lab
Anim , 42: pp. 45-61.
• Sterman, M.B.; Friar, L. (1972). "Suppression of seizures in an epileptic following sensorimotor EEG feedback
training". Electroencephalogr Clin Neurophysiol 33 (1): 89–95
• Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning". Clin
Electroencephalogr 31 (1): 45–55.
• Hammond, Corydon D. "Neurofeedback Treatment of Depression and Anxiety." Journal of Adult Development, Vol 12,
Nos. 2/3, August 2005
• Gastaut, H. (1952). "Etude electrocorticographique de al reactivite des rhytmes rolandiques". Rev. Neurol 87 (2): 176–
182
• Sny-der et al. (2008). Blinded, multi-center val-i-da-tion of EEG and rat-ing scales in iden-ti-fy-ing ADHD within a
clin-i-cal sam-ple. Psy-chi-a-try Research, 159, 346–358

22. References
• Caat, M. T., Lorist, M. M., Bezdan, E., Roerdink, J. B., & Mauritis, N. M. (2008). High-Density EEG Coherence Analysis Using
Functional Units Applied to Mental Fatigue. Journal of Neuroscience Methods, 17, pp. 271-278.
• Nuwer, M,, et al, (2005). Routine and Quantitative EEG in Mild Traumatic Brain Injury; Clinical Neurophysiology, 116.
• Thatcher, R.W., Camacho, M,, Salazar, A, Linden, C., Biver, C. and Clarke, L.: Quantitative MRI of Gray-White Matter
Distribution in Traumatic Brain Injury. Journal of Neurotrauma, Volume 14, No. 1, 1-14, 1997
• Thatcher, R.W., Moore, N, John, E.R., et al.: QEEG and Traumatic Brain Injury: Rebuttal of the American Academy of
Neurology 1997. A Report by the EEG and Clinical Neuroscience Society, Clinical Electroencephalography, 30(3): 94-98,
1999
• Khodayari-Rostamabad, A., Hasey, G. M., Maccrimmon, D. J., Reilly, J. P., & de Bruin, H. (2010). A pilot study to
determine whether machine learning methodologies using pre-treatment electroencephalography can predict the
symptomatic response to clozapine therapy. Clinical Neurophysiology, 121(12), 1998–2006
• Baskaran, A., Milev, R., & McIntyre, R. S. (2012). The neurobiology of the EEG biomarker as a predictor of treatment
response in depression. Neuropharmacology, 63(4), 507–13
• Thompson, L. et al (2010). Neurofeedback outcomes in clients with Asperger’s syndrome. Applied psychophysiology
and biofeedback, 35(1), 63–8
• Kouijzer, M., et al. (2009). Neurofeedback Treatment for Autism Spectrum Disorders: Scientific Found- ations and
Clinical Practice. Autism Spectrum Disorders – From Genes to Environment (p. 101–122)
More available on request